ZOMDF (Zomedica) Common Stock: $380.97 Mil (As of Mar. 2026)


ZOMDF Zomedica Corp ZOMDF
33 GF Score
Price $0.10
GF Value $0.19
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zomedica Common Stock?

Zomedica ZOMDF -1.09% 33 Common Stock is $380.97 Mil as of Mar. 2026. GuruFocus rates ZOMDF with a GF Score™ of 33/100 and a GF Value™ of $0.19 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Zomedica's quarterly common stock stayed the same from Sep. 2025 ($380.97 Mil) to Dec. 2025 ($380.97 Mil) and stayed the same from Dec. 2025 ($380.97 Mil) to Mar. 2026 ($380.97 Mil).

Zomedica's annual common stock stayed the same from Dec. 2023 ($380.97 Mil) to Dec. 2024 ($380.97 Mil) and stayed the same from Dec. 2024 ($380.97 Mil) to Dec. 2025 ($380.97 Mil).

Zomedica Common Stock Historical Data

* Premium members only.

The historical data trend for Zomedica's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zomedica Common Stock Chart

Zomedica Annual Data
Trend Feb16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 380.96 380.97 380.97 380.97 380.97

Zomedica Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 380.97 380.97 380.97 380.97 380.97
ZOMDF
33GF Score
Zomedica Corp ZOMDF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zomedica Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $380.97 Mil mean?
Zomedica (ZOMDF) has a Common Stock of $380.97 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zomedica and its competitors.
Is Zomedica's Common Stock too high?
Zomedica's current Common Stock is $380.97 Mil. Overall, Zomedica has a GF Score™ of 33/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zomedica's Common Stock compare to STIM and OM?
Zomedica's Common Stock of $380.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Zomedica and its competitors. Zomedica's current Common Stock is $380.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zomedica stock overvalued right now?
Based on GuruFocus' analysis, Zomedica (ZOMDF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.19, compared to a current price of $0.10 — trading 47.4% below its estimated fair value. The current Common Stock is $380.97 Mil. Zomedica's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Zomedica (ZOMDF), the current Common Stock is $380.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zomedica (ZOMDF) Overvalued in 2026?

Based on GuruFocus' analysis, Zomedica stock appears to be undervalued. The current stock price of $0.10 is trading 47.4% below its estimated GF Value™ of $0.19. GuruFocus considers Zomedica to be Significantly Undervalued.

Key valuation signals for ZOMDF:

  • Common Stock: $380.97 Mil
  • GF Value™: $0.19 vs. price of $0.10 (47.4% below fair value)
  • GF Score™: 33/100 with 3 warning signs

No single metric tells the full story. See the ZOMDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zomedica Business Description

Address 1101 Technology Drive, Suite 100, Ann Arbor, MI, USA, 48108
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its segments consist of Diagnostics, Therapeutic Devices, and Development Services. It earns the majority of revenue from the therapeutics segment, which consists of Assisi, PulseVet, and VETIGEL products.
33GF Score

Get the complete analysis for ZOMDF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$0.19
GF Value